Chong Kun Dang, Hanall to benefit from U.S. court ruling over Plavix

Published: 2007-06-28 06:59:00

Updated: 2007-06-28 06:59:00

Some domestic drug manufacturers, such as Chong Kun Dang Pharmaceutical and Hanall Pharm, who are using a different salt from Sanifi-Aventis's Plavix (clopidogrel bisulfate) will strengthen their presence in local anti-coagulant market, while sales of Plavix generic makers in Korea will be affect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK